653 related articles for article (PubMed ID: 10570432)
41. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
42. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Tuipae S; Yanaranop M; Oniem N
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
[TBL] [Abstract][Full Text] [Related]
43. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
[TBL] [Abstract][Full Text] [Related]
44. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
[TBL] [Abstract][Full Text] [Related]
45. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant pelvic irradiation in patients with node-negative carcinoma of the uterine cervix.
Uno T; Ito H; Yasuda S; Aruga T; Isobe K; Kawakami H; Mitsuhashi A; Tanaka N; Yamazawa K; Suzuka K; Sekiya S; Itami J; Shigematsu N; Kubo A
Anticancer Res; 2002; 22(2B):1213-6. PubMed ID: 12168928
[TBL] [Abstract][Full Text] [Related]
47. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
48. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
49. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix.
Thomas GM
J Natl Cancer Inst Monogr; 1996; (21):77-83. PubMed ID: 9023833
[TBL] [Abstract][Full Text] [Related]
51. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
[TBL] [Abstract][Full Text] [Related]
52. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma.
Jackson JS; Olivotto IA; Wai M D E; Grau C; Mates D; Ragaz J
Cancer; 2000 Apr; 88(8):1852-62. PubMed ID: 10760762
[TBL] [Abstract][Full Text] [Related]
53. Consequences of inadvertent, suboptimal primary surgery in carcinoma of the uterine cervix.
Münstedt K; Johnson P; von Georgi R; Vahrson H; Tinneberg HR
Gynecol Oncol; 2004 Aug; 94(2):515-20. PubMed ID: 15297197
[TBL] [Abstract][Full Text] [Related]
54. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
55. Menopausal status: a possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis.
Fregnani JH; Latorre MR; Novik PR; Lopes A; Soares FA
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):204-9. PubMed ID: 19450920
[TBL] [Abstract][Full Text] [Related]
56. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
57. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
Atasii T; Aksu MF; Cetinkaya MB
Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
[TBL] [Abstract][Full Text] [Related]
59. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
[TBL] [Abstract][Full Text] [Related]
60. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
